This email address is being protected from spambots. You need JavaScript enabled to view it.
Facebook
Twitter
SP_SOCIAL_INSTAGRAM
YouTube
Linkedin
Home
About Us
About Us
Who We Are
Our History
Global Footprint
Careers
Our Partners
Contact Us
Governance
Board of Directors
Group Executive Management
South Africa Executive Management
Group Technical Leads
What We Do
What We Do
Clinical Research
Implementation Research
Health Programmes
POP INN
Aurum Global
Global Projects
Aurum Institute Ghana
Fundação Aurum
Expertise
Tuberculosis
HIV
Health Systems
Key Populations
COVID-19
Antimicrobial resistance (AMR)
Accelerate 1
Affiliates
CHAPS
IMPAACT4TB
INNOVA
Youth Health Africa
ASHA
GHI
Library
Resources
Publications
Annual Reports
Annual Financials
News & Updates
News
Latest News
Press Releases
Aurum in the News
Multimedia
Image Gallery
Multimedia
Opinion: Shorter treatment regimens for TB offer hope, but await implementation
...
Can digital adherence technologies help with adherence to HIV medicines?
...
Failure to decrease HbA1c levels following TB treatment is associated with elevated Th1/Th17 CD4+ responses
Krause, R., Warren, C.M., Simmons, J.D., Rebeiro, P.F., Maruri, F., Karim, F., Sterling, T.R., Koethe, J.R., Leslie, A. and van der Heijden, Y.F., 2023. Failure to decrease HbA1c levels following TB t...
Can taking two pills a week slow down TB in South Africa? There’s a new plan in place
...
Aurum welcomes new TB funding commitment by donors
The Aurum Institute welcomes the recent announcement by Wellcome and the Bill & Melinda Gates Foundation to advance a tuberculosis (TB) vaccine candidate, M72/AS01E (M72), through a Phase III clin...
In-depth: How big a problem is TB in SA’s schools?
...
Aurum staff embrace Ubuntu on Nelson Mandela Day
Motivated by the Nelson Mandela quote, "It is in your hands to make a better world for all who live in it," Aurum staff in the North West province joined hands to make a difference in the lives of the...
Tuberculosis TB Preventive Treatment: The Need For Choice
...
Africa: Treating TB Contacts 'Saves Money' - Study
...
Aurum Institute Ghana Receives Grand Challenges Grant For Catalyzing Equitable Artificial Intelligence (AI) Use
Aurum Institute Ghana announced this week that it is a winner of a Grand Challenges grant – an initiative fostering innovation to solve pressing global health and development problems and funded by ...
TB contact tracing helps save lives — this is how it works in SA
...
Africans secured 60% of the Gates Foundation’s $5M fund for health-focused AI projects
...
Pharma Giant’s TB Drug Decision Welcomed, But Not All Developing Countries Benefit
...
Lancet Commission Calls for Renewed Global Response on TB
As the United Nations High-Level Meeting (UNHLM) on TB approaches, a new report from the Lancet Commission on tuberculosis releases recommendations, providing a path forward to turn the tide on this p...
Aurum Group CSO speaks at 9th Science Summit
Prof Salome Charaloumbous, Aurum Chief Science Officer participated in two sessions as a panelist at the 9th edition of the Science Summit around the 78th United Nations General Assembly (UNGA78) in N...
Fundação Aurum pharmacist passionate about his profession
As we celebrate Pharmacy Month and World Pharmacists Day 2023, we shine a spotlight on the contributions made by Fundação Aurum Pharmacist Daniel Cueteia within the communities of Maputo City, Moza...
PanTB-HM Clinical Trial Begins Recruitment in South Africa
The panTB-HM clinical trial has begun patient recruitment in South Africa, with first patient dosed on 28 July 2023. This trial is a historic milestone in the quest to revolutionise tuberculosis (TB) ...
What's behind the debate to re-authorize PEPFAR, the widely hailed anti-HIV effort?
...
US Aids fund: What is the Pepfar fight and what does it mean for Africa?
...
A phase IIb, open-label, randomized controlled dose ranging multi-centre trial to evaluate the safety, tolerability, pharmacokinetics and exposure-response relationship of different doses of delpazolid in combination with bedaquiline delamanid moxifloxacin in adult subjects with newly diagnosed, uncomplicated, smear-positive, drug-sensitive pulmonary tuberculosis
Dierig, A., Hoelscher, M., Schultz, S., Hoffmann, L., Jarchow-MacDonald, A., Svensson, E.M., Te Brake, L., Aarnoutse, R., Boeree, M., McHugh, T.D. and Wildner, L.M., 2023. A phase IIb, open-label, ran...
Enter Part of Title
Display #
5
10
15
20
25
30
50
100
All
Page 7 of 9
Start
1
2
3
4
5
6
7
8
9
End
Popular Tags
AurumNews
323
Tuberculosis
174
Public Health
128
International
127
HIV
102
Clinical Research
86
Implementation Research
79
Impaact4tb
64
COVID-19
61
Aurum Ghana
55
Unitaid
43
Aurum Mozambique
29
Most Read
Aurum staff appointed to Vanderbilt University
Aurum delivers life-saving medication to homes
World Pharmacy Month: Aurum celebrates its pharmacists
Dablapmeds: A convenient shortcut to medication collection
Recent Posts
World AIDS Day 2024: A Journey of Resilience, Hope, and Advocacy
Advancing Person-Centered Care in the HIV Response
Highlights from the Union World Conference on Lung Health 2024
Accelerate 1 Programme Highlights Community-Centric Health Solutions in Gqeberha
Home
About Us
About Us
Who We Are
Our History
Global Footprint
Careers
Our Partners
Contact Us
Governance
Board of Directors
Group Executive Management
South Africa Executive Management
Group Technical Leads
What We Do
What We Do
Clinical Research
Implementation Research
Health Programmes
POP INN
Aurum Global
Global Projects
Aurum Institute Ghana
Fundação Aurum
Expertise
Tuberculosis
HIV
Health Systems
Key Populations
COVID-19
Antimicrobial resistance (AMR)
Accelerate 1
Affiliates
CHAPS
IMPAACT4TB
INNOVA
Youth Health Africa
ASHA
GHI
Library
Resources
Publications
Annual Reports
Annual Financials
News & Updates
News
Latest News
Press Releases
Aurum in the News
Multimedia
Image Gallery
Multimedia